By Ethan Covey
Integrating facilitated telemedicine for hepatitis C virus (HCV) treatment into existing opioid treatment programs (OTPs) can lead to significant benefits, including higher cure rates, decreased drug use and fewer reinfections compared with therapy involving off-site referrals.
The approach also may increase HCV treatment access for underserved populations (JAMA 2024;331[16]:1369-1378).